Drugs / QY211
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05843422 | Mar 2023 → Oct 2024 | atopic eczema | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QY211 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05843422 ↗ |
| Route | Topical | “QY211 Gel or placebo topical applied to skin” NCT05843422 ↗ |